MEX3B is a positive pan-inflammasome regulator

Insights

Muscle Excess 3B (MEX3B), an RNA-binding protein, regulates inflammasomes controlling immune responses. Depleting MEX3B inhibits inflammasome activation, pyroptosis, and cytokine release, suggesting it as a therapeutic target for inflammation.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Inflammasomes activate inflammatory caspases, driving pyroptosis and immune responses against microbes.
  • Tight regulation of inflammasomes is crucial to prevent sepsis and autoimmune diseases.
  • Posttranslational regulation of inflammatory caspases is not well understood.

Purpose of the Study:

  • To identify novel regulators of inflammatory caspases and inflammasome activation.
  • To investigate the role of ubiquitin ligases in inflammasome posttranslational regulation.

Main Methods:

  • Generated 375 CRISPR-Cas9 ubiquitin ligase knockout lines for unbiased screening.
  • Assessed inflammasome activation, pyroptosis, and cytokine secretion in human cells and murine macrophages.
  • Investigated the functional requirement of MEX3B's RNA-binding and ubiquitin ligase activities.

Main Results:

  • Identified Muscle Excess 3B (MEX3B), an RNA-binding protein and ubiquitin ligase, as a positive regulator of the caspase-4 inflammasome.
  • Genetic depletion of MEX3B inhibited caspase-4, NLRP3, and NLRC4 inflammasomes.
  • MEX3B's role in regulating inflammasomes required its RNA-binding activity, not its ubiquitin ligase activity.

Conclusions:

  • MEX3B acts as a pan-inflammasome regulator, impacting caspase activation, pyroptosis, and cytokine secretion.
  • MEX3B is a potential therapeutic target for treating inflammatory conditions.